Olaris Partners with Thermo Fisher on Metabolomics Diagnostic Assay for Immune Response in Transplant Recipients

Olaris and Thermo Fisher Scientific are partnering to evaluate the feasibility of a machine learning and metabolomics–based diagnostic panel to assess risk of developing complications from overimmunosuppression in kidney transplant recipients

January 18, 2022

Olaris Partners with Thermo Fisher on Metabolomics Diagnostic Assay for Immune Response in Transplant Recipients